Soleno Therapeutics, Inc. (SLNO)
42.48
+0.53
(+1.26%)
USD |
NASDAQ |
Jan 16, 16:00
42.72
+0.24
(+0.56%)
After-Hours: 20:00
Soleno Therapeutics Profit Margin (Quarterly): 39.40% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AVITA Medical, Inc. | -77.29% |
| Agilon Health, Inc. | -7.68% |
| Nektar Therapeutics | -301.3% |
| Rigel Pharmaceuticals, Inc. | 40.17% |
| Marker Therapeutics, Inc. | -162.1% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -26.56% |
| Return on Assets | -20.89% |
| Return on Invested Capital | -23.20% |
| Gross Profit Margin (Quarterly) | 98.27% |
| Operating Margin (Quarterly) | 34.41% |
| Return on Net Operating Assets | -374.4% |